Trial intelligence / Profile preview

Clevudine vs Adefovir in HBeAg Positive Chronic Hepatitis B

NCT00496002Phase 3Terminated

Sponsor
Pharmasset Inc.
Start
Aug 2007
Modality
Small Molecules
Countries
12
01

Overview

A Phase 3 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by Pharmasset Inc.. Started Aug 2007; status: terminated.

02

Drugs

clevudine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00496002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00496002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call